In the next 5 to 10 years, the number of addressable patients worldwide for CAR-T cell therapies is expected to reach at least two million patients. In comparison, the global addressable patient population is currently (as of 2019) at some 450 thousand patients. This statistic depicts the estimated addressable patient population for CAR T-cell therapies worldwide in the next ten years, as of 2019.
Estimated addressable patient population for CAR-T cell therapies worldwide as of 2019*
(in 1,000)
* Estimated for global addressable patient population in relapsed or refractory stage; expected to be larger as CAR T moves to earlier lines of treatment.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
McKinsey & Company. (December 1, 2019). Estimated addressable patient population for CAR-T cell therapies worldwide as of 2019* (in 1,000) [Graph]. In Statista. Retrieved November 13, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1098463/global-addressable-patient-population-car-t-cell-therapies-estimate/
McKinsey & Company. "Estimated addressable patient population for CAR-T cell therapies worldwide as of 2019* (in 1,000)." Chart. December 1, 2019. Statista. Accessed November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1098463/global-addressable-patient-population-car-t-cell-therapies-estimate/
McKinsey & Company. (2019). Estimated addressable patient population for CAR-T cell therapies worldwide as of 2019* (in 1,000). Statista. Statista Inc.. Accessed: November 13, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1098463/global-addressable-patient-population-car-t-cell-therapies-estimate/
McKinsey & Company. "Estimated Addressable Patient Population for Car-t Cell Therapies Worldwide as of 2019* (in 1,000)." Statista, Statista Inc., 1 Dec 2019, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1098463/global-addressable-patient-population-car-t-cell-therapies-estimate/
McKinsey & Company, Estimated addressable patient population for CAR-T cell therapies worldwide as of 2019* (in 1,000) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1098463/global-addressable-patient-population-car-t-cell-therapies-estimate/ (last visited November 13, 2024)
Estimated addressable patient population for CAR-T cell therapies worldwide as of 2019* (in 1,000) [Graph], McKinsey & Company, December 1, 2019. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1098463/global-addressable-patient-population-car-t-cell-therapies-estimate/
